Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Filament Health Corp (OP: FLHLF ) 0.0373 +0.0023 (+6.57%) Streaming Delayed Price Updated: 12:05 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Filament Health Corp < Previous 1 2 3 Next > Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia February 14, 2023 Filament’s Psilocybin, Tested On Mild Cognitive Impairment By CAMH Via Benzinga EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits January 26, 2023 (Part three of a three-part series) See previous stories: EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans Via Benzinga Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More January 25, 2023 Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? Via Benzinga Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction January 20, 2023 Clinical-stage natural psychedelics developer Filament Health (OTCQB: FLHLF) and the Psychiatric Center Copenhagen’s collaborative clinical trial has been approved by the Danish Medicines Agency and is... Via Benzinga 6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements January 10, 2023 Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space. Via Benzinga Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More December 19, 2022 Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. Via Benzinga EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill December 16, 2022 Part two of a three-part series. Previous story: Standardized Ayahuasca Pill Is Officially Here, Feast Yourself With The Exclusive Details & Insights Via Benzinga Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU December 15, 2022 Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal. Via Benzinga EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans December 15, 2022 Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. Via Benzinga Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga Natural Psychedelics Extraction & Standardization Obtains Two New US Patents December 01, 2022 Clinical-stage psychedelics drug development company Filament Health Corp. Via Benzinga Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup November 15, 2022 Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics Via Benzinga Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier November 11, 2022 Clinical-stage natural psychedelic drug development company Filament Health Corp. (OTCQB: FLHLF) reported its third quarter financial results and operational highlights for the period ended September... Via Benzinga Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More November 07, 2022 Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' Via Benzinga EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' November 04, 2022 Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a... Via Benzinga Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs July 08, 2022 Clinical-stage natural psychedelics company Filament Health Corp. Via Benzinga Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments June 16, 2022 For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment. Via Benzinga Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill June 15, 2022 Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. Via Benzinga Two Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders June 09, 2022 Filament Health Corp. (OTCQB: FLHLF) and Jaguar Health, Inc. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement. Via Benzinga Optimi Health Signs Two New Supply Agreements In Less Than a Week May 31, 2022 Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. Via Benzinga Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say May 20, 2022 Patents are the golden eggs of the booming psychedelic space. Via Benzinga Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth April 27, 2022 Just two weeks ago, Filament Health (OTCQB: FLHLF) was issued a patent by the U. S. Patent and Trademark Office to extract and standardize natural psilocybin. Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market April 22, 2022 Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines. Via Benzinga Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know April 19, 2022 Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the... Via Benzinga Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin April 13, 2022 Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and... Via Benzinga Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins February 07, 2022 This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. Via Benzinga Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants January 31, 2022 Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants. Via Benzinga Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington January 10, 2022 Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... Via Benzinga How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions November 16, 2021 Image by Mathew Schwartz from Unsplash The following post was written and/or pu... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.